Eikon Therapeutics, Inc. · NASDAQ:EIKN
Abu Dhabi Investment Authority reported a 5.20% stake in Eikon Therapeutics, Inc. (Schedule 13G)
Event Feb 4, 2026 · Filed Feb 18, 2026
Abu Dhabi Investment Authority reported a 5.20% stake in Eikon Therapeutics, Inc., 2,816,714 shares, as a passive investor on Feb 4, 2026. Filed Feb 18, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 2,816,714
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Abu Dhabi Investment Authority | 5.20% | 2,816,714 |
| Platinum Falcon B 2018 RSC Limited | 2.10% | 1,147,138 |
Source
Related
- Eikon Therapeutics, Inc.
- Abu Dhabi Investment Authority
- Eikon Therapeutics, Inc. shareholders
- Schedule 13G/A · Abu Dhabi Investment Authority · Oct 2, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kutzkey Tim · Sep 8, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Innovation Endeavors III LP · May 15, 2026
- Schedule 13G · Perlmutter Roger M · May 13, 2026